The DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Oxidative stress promotes myofibroblast differentiation and tumour spreading
Open accessAbstract
JunD regulates genes involved in antioxidant defence. We took advantage of the chronic oxidative stress resulting from junD deletion to examine the role of reactive oxygen species (ROS) in tumour development. In a model of mammary carcinogenesis, junD inactivation increased tumour incidence and revealed an associated reactive stroma. junD-inactivation in the stroma was sufficient to shorten tumour-free survival rate and enhance metastatic spread. ROS promoted conversion of fibroblasts into highly migrating myofibroblasts through accumulation of the hypoxia-inducible factor (HIF)-1alpha transcription factor and the CXCL12 chemokine. Accordingly, treatment with an antioxidant reduced the levels of HIF and CXCL12 and numerous myofibroblast features. CXCL12 accumulated in the stroma of HER2-human breast adenocarcinomas. Moreover, HER2 tumours exhibited a high proportion of myofibroblasts, which was significantly correlated to nodal metastases. Interestingly, this subset of tumours exhibited a significant nuclear exclusion of JunD and revealed an associated oxido-reduction signature, further demonstrating the relevance of our findings in human cancers. Collectively, our data uncover a new mechanism by which oxidative stress increases the migratory properties of stromal fibroblasts, which in turn potentiate tumour dissemination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CAFs and ROS engage in two-way cross-talk: on the one hand, fibroblasts are targeted by ROS, particularly H2O2, which is able to convert them into active CAFs through the upregulation of HIF1α; on the other hand, CAFs are critical for the increase in ROS levels observed in cancer50,51.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,175
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J. S., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,677
Cited by
Sorted by citations
Hayes, J. D., Dinkova-Kostova, A. T., & Tew, K. D. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.001 · Cited by 2,654
ROS in cancer therapy: the bright side of the moon
Perillo, B., Di Donato, M., Pezone, A., Di Zazzo, E., Giovannelli, P., Galasso, G., Castoria, G., & Migliaccio, A. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0384-2 · Cited by 2,176
Turning foes to friends: targeting cancer-associated fibroblasts
Chen, X., & Song, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0004-1 · Cited by 1,929
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Costa, A., Kieffer, Y., Scholer-Dahirel, A., Pelon, F., Bourachot, B., Cardon, M., Sirven, P., Magagna, I., Fuhrmann, L., Bernard, C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.011 · Cited by 1,705
Self-citationThe role of ROS in tumour development and progression
Cheung, E. C., & Vousden, K. H. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-021-00435-0 · Cited by 1,663
Bissell, M. J., & Hines, W. C. (2011) · Nature Medicine · doi:10.1038/nm.2328 · Cited by 1,584
Oxidative stress and cancer: An overview
Iglesias, V. S., Moliné, T., Somoza, R., Paciucci, R., Kondoh, H., & LLeonart, M. E. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.10.004 · Cited by 1,488
Diversity and biology of cancer-associated fibroblasts
Biffi, G., & Tuveson, D. A. (2021) · Physiological Reviews · doi:10.1152/physrev.00048.2019 · Cited by 1,265
Recent Developments in Myofibroblast Biology
Hinz, B., Phan, S. H., Thannickal, V. J., Prunotto, M., Desmoulière, A., Varga, J., De Wever, O., Mareel, M., & Gabbiani, G. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.02.004 · Cited by 1,193
Fibroblast heterogeneity in the cancer wound
Öhlund, D., Elyada, E., & Tuveson, D. A. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20140692 · Cited by 982
Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer.
Kieffer, Y., Hocine, H. R., Gentric, G., Pelon, F., Bernard, C., Bourachot, B., Lameiras, S., Albergante, L., Bonneau, C., Guyard, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1384 · Cited by 910
Self-citationCancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Shiga, K., Hara, M., Nagasaki, T., Sato, T., Takahashi, H., & Takeyama, H. (2015) · Cancers · doi:10.3390/cancers7040902 · Cited by 774
Fiaschi, T., Marini, A., Giannoni, E., Taddei, M. L., Gandellini, P., Donatis, A. D., Lanciotti, M., Serni, S., Cirri, P., & Chiarugi, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1949 · Cited by 598
Comito, G., Giannoni, E., Segura, C. P., Barcellos‐de‐Souza, P., Raspollini, M. R., Baroni, G., Lanciotti, M., Serni, S., & Chiarugi, P. (2013) · Oncogene · doi:10.1038/onc.2013.191 · Cited by 546
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression
Cirri, P., & Chiarugi, P. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9340-x · Cited by 529
Reactive Oxygen Species in the Tumor Microenvironment: An Overview
Weinberg, F., Ramnath, N., & Nagrath, D. (2019) · Cancers · doi:10.3390/cancers11081191 · Cited by 502
Karagiannis, G. S., Poutahidis, T., Erdman, S. E., Kirsch, R., Riddell, R. H., & Diamandis, E. P. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0307 · Cited by 507
Cancer associated fibroblasts: the dark side of the coin.
Cirri, P., & Chiarugi, P. (2011) · Europe PMC (PubMed Central) · Cited by 512
miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
Mateescu, B., Batista, L., Cardon, M., Gruosso, T., de Feraudy, Y., Mariani, O., Nicolas, A., Meyniel, J.-P., Cottu, P., Sastre-Garau, X., et al. (2011) · Nature Medicine · doi:10.1038/nm.2512 · Cited by 502
Self-citationFibroblasts in cancer: Unity in heterogeneity
Chhabra, Y., & Weeraratna, A. T. (2023) · Cell · doi:10.1016/j.cell.2023.03.016 · Cited by 505
Activated fibroblasts in cancer: Perspectives and challenges
Caligiuri, G., & Tuveson, D. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.015 · Cited by 450
Activation of fibroblasts in cancer stroma
Räsänen, K., & Vaheri, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.032 · Cited by 499
Evidence for a stromal-epithelial “lactate shuttle” in human tumors
Whitaker‐Menezes, D., Martinez‐Outschoorn, U., Lin, Z., Ertel, A., Flomenberg, N., Witkiewicz, A. K., Birbe, R., Howell, A., Pavlides, S., Gândara, R., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.11.15659 · Cited by 433
Autophagy in cancer associated fibroblasts promotes tumor cell survival
Martinez‐Outschoorn, U., Trimmer, C., Zhao, L., Whitaker‐Menezes, D., Chiavarina, B., Zhou, J., Wang, C., Pavlides, S., Cantarin, M. P. M., Capozza, F., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.17.12928 · Cited by 413
Pelon, F., Bourachot, B., Kieffer, Y., Magagna, I., Mermet‐Meillon, F., Bonnet, I., Costa, A., Givel, A.-M., Atieh, Y., Barbazán, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14134-w · Cited by 404
Self-citationCancer-associated fibroblasts in tumor microenvironment–Accomplices in tumor malignancy
Liao, Z., Tan, Z. W., Zhu, P., & Tan, N. S. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2017.12.003 · Cited by 335
The role of reactive oxygen species and metabolism on cancer cells and their microenvironment
Costa, A., Scholer‐Dahirel, A., & Mechta‐Grigoriou, F. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.12.007 · Cited by 344
Self-citationExtracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics
Islam, M. S., Ciavattini, A., Petraglia, F., Castellucci, M., & Ciarmela, P. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx032 · Cited by 329
Mechanotransduction in tumor progression: The dark side of the force
Broders-Bondon, F., Nguyen Ho-Bouldoires, T. H., Fernandez-Sanchez, M.-E., & Farge, E. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201701039 · Cited by 319
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
Givel, A.-M., Kieffer, Y., Scholer-Dahirel, A., Sirven, P., Cardon, M., Pelon, F., Magagna, I., Gentric, G., Costa, A., Bonneau, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03348-z · Cited by 295
Self-citationOxidative Stress, Tumor Microenvironment, and Metabolic Reprogramming: A Diabolic Liaison
Fiaschi, T., & Chiarugi, P. (2012) · International Journal of Cell Biology · doi:10.1155/2012/762825 · Cited by 321
Caveolin-1 and Cancer Metabolism in the Tumor Microenvironment: Markers, Models, and Mechanisms
Sotgia, F., Martinez‐Outschoorn, U., Howell, A., Pestell, R. G., Pavlides, S., & Lisanti, M. P. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-120856 · Cited by 290
Cancer, Oxidative Stress, and MetastasisPreprint
Gill, J. G., Piskounova, E., & Morrison, S. J. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030791 · Cited by 278
Fibroblasts as architects of cancer pathogenesis
Marsh, T., Pietras, K., & McAllister, S. S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.10.013 · Cited by 277
Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
Mhaidly, R., & Mechta‐Grigoriou, F. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101417 · Cited by 267
Self-citationMhaidly, R., & Mechta‐Grigoriou, F. (2021) · Immunological Reviews · doi:10.1111/imr.12978 · Cited by 231
Self-citationCancer Associated Fibroblasts: The Architects of Stroma Remodeling
Santi, A., Kugeratski, F. G., & Zanivan, S. R. (2017) · PROTEOMICS · doi:10.1002/pmic.201700167 · Cited by 251
World Journal of Pharmaceutical Sciences
(2021) · World Journal of Pharmaceutical Sciences · doi:10.54037/wjps · Cited by 246
Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment
Casazza, A., Conza, G. D., Wenes, M., Finisguerra, V., Deschoemaeker, S., & Mazzone, M. (2013) · Oncogene · doi:10.1038/onc.2013.121 · Cited by 254
Heterogeneity in Cancer Metabolism: New Concepts in an Old Field
Gentric, G., Mieulet, V., & Mechta‐Grigoriou, F. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6750 · Cited by 248
Self-citationHydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis
Lisanti, M. P., Martinez‐Outschoorn, U., Zhao, L., Pavlides, S., Whitaker‐Menezes, D., Pestell, R. G., Howell, A., & Sotgia, F. (2011) · Cell Cycle · doi:10.4161/cc.10.15.16870 · Cited by 233
EMT and Oxidative Stress: A Bidirectional Interplay Affecting Tumor Malignancy
Giannoni, E., Parri, M., & Chiarugi, P. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4280 · Cited by 234
The Warburg effect: Evolving interpretations of an established concept
Chen, X., Qian, Y., & Wu, S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.08.027 · Cited by 234
Myofibroblast differentiation and survival in fibrotic disease
Kis, K., Liu, X., & Hagood, J. S. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001967 · Cited by 230
Caveolae and signalling in cancer
Martinez‐Outschoorn, U., Sotgia, F., & Lisanti, M. P. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3915 · Cited by 216
Giannoni, E., Bianchini, F., Calorini, L., & Chiarugi, P. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3727 · Cited by 218
Martinez‐Outschoorn, U., Sotgia, F., & Lisanti, M. P. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.03.002 · Cited by 211
CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion
Günaydın, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.668349 · Cited by 211
Role of Oxidative Stress and the Microenvironment in Breast Cancer Development and Progression
Jezierska‐Drutel, A., Rosenzweig, S. A., & Neumann, C. A. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00003-4 · Cited by 203
Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4
Hanley, C. J., Mellone, M., Ford, K., Thirdborough, S. M., Mellows, T., Frampton, S. J., Smith, D. M., Harden, E., Szyndralewiez, C., Bullock, M., et al. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx121 · Cited by 195
Drug targeting to myofibroblasts: Implications for fibrosis and cancer
Yazdani, S., Bansal, R., & Prakash, J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.010 · Cited by 191
Bekir, J., Mars, M., Souchard, J., & Bouajila, J. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.01.036 · Cited by 195
CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis
Mortezaee, K. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117534 · Cited by 180
Gruosso, T., Mieulet, V., Cardon, M., Bourachot, B., Kieffer, Y., Devun, F., Dubois, T., Dutreix, M., Vincent‐Salomon, A., Miller, K. M., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505891 · Cited by 179
Self-citationSotgia, F., Martinez‐Outschoorn, U., Pavlides, S., Howell, A., Pestell, R. G., & Lisanti, M. P. (2011) · Breast Cancer Research · doi:10.1186/bcr2892 · Cited by 179
Cassim, S., Vučetić, M., Ždralević, M., & Pouysségur, J. (2020) · Cancers · doi:10.3390/cancers12051119 · Cited by 183
Lefort, S., Joffre, C., Kieffer, Y., Givel, A.-M., Bourachot, B., Zago, G., Bieche, I., Dubois, T., Meseure, D., Vincent-Salomon, A., et al. (2014) · Autophagy · doi:10.4161/15548627.2014.981788 · Cited by 173
Self-citationCuiffo, B., Campagne, A., Bell, G. W., Lembo, A., Orso, F., Lien, E. C., Bhasin, M., Raimo, M., Hanson, S. E., Marusyk, A., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.10.001 · Cited by 175
Self-citationDeciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer
Croizer, H., Mhaidly, R., Kieffer, Y., Gentric, G., Djerroudi, L., Leclère, R., Pelon, F., Robley, C., Bohec, M., Meng, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47068-z · Cited by 183
Self-citationOxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers
Liang, X., Weng, J., You, Z., Wang, Y., Wen, J., Xia, Z., Huang, S., Luo, P., & Cheng, Q. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02375-x · Cited by 204
Augsten, M., Sjöberg, E., Frings, O., Vorrink, S. U., Frijhoff, J., Olsson, E., Borg, Å., & Östman, A. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2740 · Cited by 167
Inflammatory pathways in the early steps of colorectal cancer development
Mariani, F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9716 · Cited by 161
Wu, M., Hong, H.-C., Hong, T.-M., Chiang, W.-F., Jin, Y., & Chen, Y. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1824 · Cited by 152
IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis
Pallangyo, C. K., Ziegler, P. K., & Greten, F. R. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20150576 · Cited by 142
Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT
Francesco, E. M. D., Maggiolini, M., & Musti, A. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072011 · Cited by 148
Sotgia, F., Martinez‐Outschoorn, U., & Lisanti, M. P. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-62 · Cited by 140
Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells
Bonuccelli, G., Avnet, S., Grisendi, G., Salerno, M., Granchi, D., Dominici, M., Kusuzaki, K., & Baldini, N. (2014) · Oncotarget · doi:10.18632/oncotarget.2243 · Cited by 140
Balliet, R. M., Capparelli, C., Guido, C., Pestell, T. G., Martinez‐Outschoorn, U., Zhao, L., Whitaker‐Menezes, D., Chiavarina, B., Pestell, R. G., Howell, A., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.23.18254 · Cited by 138
Cancer: An Oxidative Crosstalk between Solid Tumor Cells and Cancer Associated Fibroblasts
Arcucci, A., Ruocco, M. R., Granato, G., Sacco, A. M., & Montagnani, S. (2016) · BioMed Research International · doi:10.1155/2016/4502846 · Cited by 139
The Relationship of Redox With Hallmarks of Cancer: The Importance of Homeostasis and Context
Xing, F., Hu, Q., Qin, Y., Xu, J., Zhang, B., Yu, X., & Wang, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.862743 · Cited by 142
Fiaschi, T., Giannoni, E., Taddei, L., Cirri, P., Marini, A., Pintus, G., Nativi, C., Richichi, B., Scozzafava, A., Carta, F., et al. (2013) · Cell Cycle · doi:10.4161/cc.24902 · Cited by 135
Ren, Y., Wang, R., Weng, S., Xu, H., Zhang, Y., Chen, S., Liu, S., Ba, Y., Zhou, Z., Luo, P., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01831-w · Cited by 149
Crawford, S. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00068 · Cited by 108
Cellular Interactions in the Tumor Microenvironment: The Role of Secretome
da Cunha, B. R., Domingos, C., Stefanini, A. C. B., Henrique, T., Polachini, G. M., Castelo‐Branco, P., & Tajara, E. H. (2019) · Journal of Cancer · doi:10.7150/jca.21780 · Cited by 133
Yoon, H., Tang, C., Banerjee, S., Delgado, A. L., Yebra, M., Davis, J. E., & Sicklick, J. K. (2021) · Oncogenesis · doi:10.1038/s41389-021-00302-5 · Cited by 125
Cancer Metabolism Drives a Stromal Regenerative Response
Schwörer, S., Vardhana, S. A., & Thompson, C. B. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.015 · Cited by 125
Lewińska, A., Adamczyk‐Grochala, J., Kwasniewicz, E., Deręgowska, A., & Wnuk, M. (2017) · APOPTOSIS · doi:10.1007/s10495-017-1353-7 · Cited by 122
Senescent stroma promotes prostate cancer progression: The role of miR‐210
Taddei, M. L., Cavallini, L., Comito, G., Giannoni, E., Folini, M., Marini, A., Gandellini, P., Morandi, A., Pintus, G., Raspollini, M. R., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.009 · Cited by 122
Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells
Lisek, K., Campaner, E., Ciani, Y., Walerych, D., & Sal, G. D. (2018) · Oncotarget · doi:10.18632/oncotarget.24974 · Cited by 119
Peiris-Pagès, M., Sotgia, F., & Lisanti, M. P. (2015) · Oncotarget · doi:10.18632/oncotarget.3828 · Cited by 115
The Roles of MicroRNA-141 in Human Cancers: From Diagnosis to Treatment
Gao, Y., Feng, B. C., Han, S., Zhang, K., Chen, J., Li, C., Wang, R., & Chen, L. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000438641 · Cited by 114
Paneni, F., Osto, E., Costantino, S., Mateescu, B., Schumacher, S. B., Coppolino, G., Perna, E., Mocharla, P., Akhmedov, A. T., Kubant, R., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000826 · Cited by 110
Self-citationRadhakrishnan, R., Ha, J. H., Jayaraman, M., Liu, J., Moxley, K. M., Isidoro, C., Sood, A. K., Song, Y. S., & Dhanasekaran, D. N. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.11.023 · Cited by 108
The dynamic roles of the bladder tumour microenvironment
Lee, Y., Lam, H., Rosser, C. J., Theodorescu, D., Parks, W. C., & Chan, K. S. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00608-y · Cited by 111
Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies
Zhou, X., An, B., Lin, Y., Ni, Y., Zhao, X., & Liang, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115036 · Cited by 112
Trimmer, C., Sotgia, F., Whitaker‐Menezes, D., Balliet, R. M., Eaton, G. J., Martinez‐Outschoorn, U., Pavlides, S., Howell, A., Iozzo, R. V., Pestell, R. G., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.4.14101 · Cited by 107
Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma
Sperb, N., Tsesmelis, M., & Wirth, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155486 · Cited by 109
Cancer-Associated Fibroblasts as Targets for Immunotherapy
Kakarla, S., Song, X., & Gottschalk, S. M. (2012) · Immunotherapy · doi:10.2217/imt.12.112 · Cited by 105
Cancer Associated Fibroblasts: Naughty Neighbors That Drive Ovarian Cancer Progression
Dasari, S., Fang, Y., & Mitra, A. K. (2018) · Cancers · doi:10.3390/cancers10110406 · Cited by 102
Paracrine tumor signaling induces transdifferentiation of surrounding fibroblasts
Heneberg, P. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.09.008 · Cited by 105
Regulation of redox signaling in HIF‐1‐dependent tumor angiogenesis
Manuelli, V., Pecorari, C., Filomeni, G., & Zito, E. (2021) · FEBS Journal · doi:10.1111/febs.16110 · Cited by 108
Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging
Peltier, A., Seban, R., Buvat, I., Bidard, F., & Mechta‐Grigoriou, F. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.04.008 · Cited by 96
Self-citationPhytomedicine—Modulating oxidative stress and the tumor microenvironment for cancer therapy
Cheng, Y., Yang, C.-C., & Shyur, L. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.10.022 · Cited by 100
Caveolin-1 and Accelerated Host Aging in the Breast Tumor Microenvironment
Mercier, I., Camacho, J., Titchen, K., Gonzales, D. M., Quann, K., Bryant, K. G., Molchansky, A., Milliman, J. N., Whitaker-Menezes, D., Sotgia, F., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.03.017 · Cited by 96
Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models
Gupta, P., & Srivastava, S. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-80 · Cited by 92
Epigenetics and Immunometabolism in Diabetes and Aging
Guzik, T. J., & Cosentino, F. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7299 · Cited by 94
Peng, Q., Zhao, L., Hou, Y., Sun, Y., Wang, L., Luo, H., Peng, H., & Liu, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060321 · Cited by 89
Zeng, W., Xiong, L., Wu, W., Li, S., Liu, J., Yang, L., Lao, L., Huang, P., Zhang, M., Chen, H., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02540-2 · Cited by 88
CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
Lefort, S., Thuleau, A., Kieffer, Y., Sirven, P., Bièche, I., Marangoni, E., Vincent‐Salomon, A., & Mechta‐Grigoriou, F. (2016) · Oncogene · doi:10.1038/onc.2016.284 · Cited by 89
Self-citationHuang, X., He, C., Hua, X., Kan, A., Mao, Y., Sun, S., Duan, F., Wang, J., Huang, P., & Li, S. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.41 · Cited by 85
Metadata
- Authors
- Toullec, A., Gerald, D., Despouy, G., Bourachot, B., Cardon, M., Lefort, S., Richardson, M., Rigaill, G., Parrini, M., Lucchesi, C., Bellanger, D., Stern, M., Dubois, T., Sastre‐Garau, X., Delattre, O., Vincent‐Salomon, A., & Mechta‐Grigoriou, F.
- Affiliations
- Inserm (FR)
- Institut Curie (FR)
- Corresponding author
- Mechta‐Grigoriou, Fatima
- ORCID
- Venue
- EMBO Molecular Medicine
- Published
- 2010-06-01
- Volume
- 2
- Issue
- 6
- Pages
- 211-230
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC3377319
- OpenAlex
- W2107028932
- Cited by
- 339
- References
- 91
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 27 · 2023: 38 · 2022: 33 · 2021: 30 · 2020: 23 · 2019: 12 · 2018: 11 · 2017: 17 · 2016: 14 · 2015: 13 · 2014: 19 · 2013: 22 · 2012: 22
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- EMBO Molecular Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-nc)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Institut Curie
- Fondation de France
- Agence Nationale de la Recherche
- French National Institut of Cancer
- Association pour la Recherche contre le Cancer
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- oxidative stress, JunD, myofibroblast differentiation, tumour metastasis, reactive oxygen species, mammary carcinogenesis, stromal fibroblasts, HIF-1α, CXCL12, HER2-positive breast cancer, antioxidant therapy, tumor microenvironment, hypoxia
- MeSH terms
- Animals, Breast Neoplasms, Cell Differentiation, Cell Line, Female, Fibroblasts, Histocytochemistry, Humans, Immunohistochemistry, Locomotion, Microscopy, Microscopy, Fluorescence, Models, Biological, Neoplasm Metastasis, Proto-Oncogene Proteins, Mammary Neoplasms, Animal, Incidence, Survival Analysis, Proto-Oncogene Proteins c-jun, Reactive Oxygen Species, Mice, Knockout, Oxidative Stress, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, Chemokine CXCL12
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
